Concepedia

Veit Bücklein

VB

47

Publications

3K

Citations

30

H-Index

2013

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

Heidelberg University

German Cancer Research Center

Helmholtz Zentrum München

Veit Bücklein is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2013–2025

47

Publications

47

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

, , +16

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez Perez, Pierre Sesques et al. · Blood · 2021 · 398 citations · Full text

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

Nora Philipp, Maryam Kazerani, Alyssa Nicholls et al. · Blood · 2022 · 215 citations · Full text

, , +23

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni et al. · Journal for ImmunoTherapy of Cancer · 2022 · 169 citations · Full text

Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE® (Bispecific T-Cell Engager) in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Marion Subklewe, Anthony S. Stein, Roland B. Walter et al. · Blood · 2019 · 86 citations

Rows per page

1–5 of 47